03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Apo-Ranitidine 300mg* : | |
Type | Medicine Non Marketed |
Originator | Zantac Tablets 300mg |
Agent | Promopharm |
Distributor | Promopharm |
Laboratory | Apotex |
Responsible Party | Apotex Inc |
Origin | Canada |
Manufacturer | Apotex Inc |
Manufacturing Type | G |
Origin | Canada |
ATC | A02BA02 |
Apo-Ranitidine 300mg* :
Apo-Ranitidine 300mg* :
Apo-Ranitidine 300mg* :
Apo-Ranitidine 300mg* :
Apo-Ranitidine 300mg* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Apo-Ranitidine 300mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Uncommon |
Acute interstitial nephritis | Very rare |
Agranulocytosis | Very rare |
Alopecia | Very rare |
Anaphylactic shock | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Arthralgia (Pain joint) (Joint ache) | Very rare |
Asystole | Very rare |
Atrioventricular block (AVB) | Very rare |
Bone marrow depression | Very rare |
Bone marrow failure (Myelosuppression) | Very rare |
Bradycardia | Very rare |
Bronchospasm | Rare |
Chest pain | Rare |
Constipation | Uncommon |
Depression | Very rare |
Diarrhoea (Diarrhea) | Very rare |
Dizziness | Very rare |
Dyspnoea (dyspnea) | Not known |
Erythema multiforme | Very rare |
Fever | Rare |
Galactorrhoea | Very rare |
Gynecomastia (Gynaecomastia) | Very rare |
Hallucination | Very rare |
Headache | Very rare |
Hepatitis | Very rare |
Hypersensitivity reactions | Rare |
Hypotension | Rare |
Impotence | Very rare |
Jaundice | Very rare |
Leucopenia (Leukopenia) | Very rare |
Liver function test abnormal | Rare |
Mental confusion | Very rare |
Movements involuntary | Very rare |
Myalgia | Very rare |
Nausea | Uncommon |
Pancreatitis acute | Very rare |
Pancytopenia | Very rare |
Plasma creatinine increased | Rare |
Skin rash | Rare |
Tachycardia | Very rare |
Thrombocytopenia (Thrombopenia) | Very rare |
Urticaria | Rare |
Vasculitis | Very rare |
Vision blurred | Very rare |
Apo-Ranitidine 300mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Apo-Ranitidine 300mg* MoH 1005 :
Form | Tablet |
Package Size | Box of 100 |
Strength | 300mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 27361 |
Submission date | 01/01/1992 |
Registration Year | 1992 |
Archived Date | 2014 |
Price Comparison
● Country: | Qatar | |
● Package Size: | 30 | |
● Public Price: | 90 QAR | ( 2,210,220.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 3 QAR | ( 73,674.00 LBP ) |
● Pharmacy Price: | 73.86476864 QAR | ( 1813970.9882611 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 30 | |
● Public Price: | 72.5 AED | ( 1,751,672.50 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2,4167 AED | ( 48,322.00 LBP ) |
● Pharmacy Price: | 58.37 AED | ( 1410277.57 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UAE | |
● Package Size: | 30's (10's Blister x 3) | |
● Public Price: | 72.5 AED | ( 1,751,672.50 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2,4167 AED | ( 48,322.00 LBP ) |
● Pharmacy Price: | 58.37 AED | ( 1410277.57 LBP ) |
● Pricing Date: | 21/08/2019 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 30 | |
● Public Price: | 80.45 SAR | ( 1,901,838.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2,6817 SAR | ( 47,280.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
● Country: | Spain | |
● Package Size: | 28 | |
● Public Price: | 7.77 EUR | ( 752,726.52 LBP ) |
● Pack size unit used: | 28 | |
● Cost/Unit: | 0,2775 EUR | ( 0.00 LBP ) |
● Pharmacy Price: | 4.98 EUR | ( 482442.48 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands |
● Package Size: | 100 |
● Reference: | Zorginstituut Nederland |
● Pricing Date: | 15/06/2019 |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File